atai Life Sciences (ATAI)
(Delayed Data from NSDQ)
$1.51 USD
-0.06 (-3.82%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $1.49 -0.02 (-1.32%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.17 |
EPS Last Quarter | -0.17 |
Last EPS Surprise | 15.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.67 |
Next Year | -0.67 |
EPS (TTM) | -0.64 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 1.50M | 1.50M |
# of Estimates | NA | NA | 1 | 1 |
High Estimate | NA | NA | 1.50M | 1.50M |
Low Estimate | NA | NA | 1.50M | 1.50M |
Year ago Sales | 0.17M | 0.09M | 0.31M | 1.50M |
Year over Year Growth Est. | NA | NA | 377.71% | 0.00% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.17 | -0.18 | -0.67 | -0.67 |
# of Estimates | 3 | 2 | 4 | 3 |
Most Recent Consensus | NA | NA | -0.72 | -0.53 |
High Estimate | -0.16 | -0.16 | -0.62 | -0.53 |
Low Estimate | -0.19 | -0.19 | -0.72 | -0.79 |
Year ago EPS | -0.21 | -0.14 | -0.25 | -0.67 |
Year over Year Growth Est. | 19.05% | -28.57% | -168.00% | -0.25% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.17 | -0.18 | -0.67 | -0.67 |
7 Days Ago | -0.17 | -0.18 | -0.67 | -0.67 |
30 Days Ago | -0.17 | -0.18 | -0.67 | -0.67 |
60 Days Ago | -0.17 | -0.18 | -0.69 | -0.67 |
90 Days Ago | -0.19 | -0.19 | -0.80 | -0.77 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.17 | -0.18 | -0.67 | -0.67 |
Zacks Consensus Estimate | -0.17 | -0.18 | -0.67 | -0.67 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.17 | -0.12 | -0.14 | -0.21 | NA |
Estimate | -0.20 | -0.17 | -0.20 | -0.21 | NA |
Difference | 0.03 | 0.05 | 0.06 | 0.00 | 0.04 |
Surprise | 15.00% | 29.41% | 30.00% | 0.00% | 18.60% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more